Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPT with Sulfadoxine-Pyrimethamine in Pregnant Women in Zambia
NCT00270530Phase 4Completed
- Sponsor
- Center for International Health and Development
- Start
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sulfadoxine + pyrimethamine in malaria (2 arms), sponsored by Center for International Health and Development. Primary endpoints: Prevalence of placental malaria infection and Prevalence of maternal peripheral parasitemia. Started Nov 2002; status: completed.
02
Drugs
sulfadoxine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00270530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00270530.